BioWorld

Nov. 27, 2001

View Archived Issues

Inex Selling $25M In Stock To Fund Pipeline Development

Read More

Other News To Note

Read More

Monsanto Paying Mendel $20M In Deal Focused On Agriculture

Read More

Isis, OncoGenex Combine Forces To Develop Drug Against Cancer

Read More

Gilead Sells Oncology Pipeline To OSI: $170M In Cash, Stock

Read More

Millennium Partners Two Drugs, Licenses In Another Technology

Read More

Advanced Cell Technology Stirs Debate With Embryo Cloning

Read More